U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Brilliant Enterprises LLC - 609523 - 12/06/2021
  1. Warning Letters

CLOSEOUT LETTER

Brilliant Enterprises LLC MARCS-CMS 609523 —

Delivery Method:
Via Email
Reference #:
FY 21- HAFE6 WL- 03
Product:
Food & Beverages
Recipient:
Recipient Name
Adam and Angela Schultz
Brilliant Enterprises LLC

621 Main Street
Unit 182
Gaylord, MI 49735
United States

support@levelupmushrooms.com
Issuing Office:
Office of Human and Animal Food Operations Division- East 6

United States

Dear Adam and Angela Schultz,

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter FY 21- HAFE6 WL- 03. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Lauren E. Sexton
Compliance Officer
Office of Human and Animal Food Operations
Division East 6

Back to Top